Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barry Skikne, MD, FACP, FCP (SA)
Celgene Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- California Cancer Care Inc
Greenbrae, California, United States
- Main Cancer Centers of Florida, P.A.
Ocoee, Florida, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Northwest Cancer Specialists, P.C.
Albuquerque, New Mexico, United States
- Willamette Valley Cancer Institute
Springfield, Oregon, United States
- University of Texas- Md Anderson
Houston, Texas, United States
- Hematology and Oncology Assoc. of South Texas
San Antonio, Texas, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Yakima Valley Memorial Hospital/ North Star Lodge
Yakima, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Aug 2008
- Primary completion
- 6 Apr 2016
- Completion
- 7 Apr 2016
- Last update posted
- 8 Nov 2019
- Registered enrollment
- 31
- Registry id
- NCT00761722
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.